Sebastian Wendy, Roy Atanu, Kini Usha, Mullick Shalini
Department of Pathology, St John's Medical College, Bangalore 560 034, India.
Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):427-32. doi: 10.4103/0377-4929.68262.
Immunity status, individual response to disease and types of antibodies produced are well known to vary from person to person, place to place and probably from population to population. A broad spectrum of specific auto antibodies that have so far been associated with specific rheumatic diseases, as noted in Western literature, has been well taken as a reference standard all over the world. There is neither research work nor any data correlating the auto antibodies and their antinuclear antibody (ANA) patterns with the immunoprofile in the Indian population to date.
To understand a definite association between ANA patterns and specific antibodies in the serum in the Indian study population and to document similarities / differences with the West.
This prospective and retrospective double blind study was undertaken on the South Indian population referred for ANA testing by Indirect Immunofluorescence method and by immunoline methods.
Serum samples of patients from a random South Indian population who sought medical help for rheumatic disease were subjected for ANA testing by indirect immunofluorescence (IIF) method and line immunoassay during the study period of 27 months. Serum samples were processed in dilution of 1:100 using HEp - 2010 / liver biochip (Monkey) (EUROIMMUN AG). The serum samples which were further processed for line immunoassay were treated in 1:100 dilution on nylon strips coated with recombinant and purified antigens as discrete lines with plastic backing (EUROIMMUN AG) coated with antigens nRNP / Sm, Sm, SSA, Ro-52, SSB, Scl-70, PM-Scl, PCNA, Jo-1, CENP-B, dsDNA, nucleosomes, histones, ribosomal protein-P, anti-mitochondrial antibodies (AMA-M2) along with a control band. The analysis was done by comparing the intensity of the reaction with positive control line by image analysis.
The antinuclear antibody indirect immunofluorescence (ANA - IIF) patterns obtained were projectable to visualize a certain spectrum of specific antibodies such as homogenous (45.5%) with dsDNA, nucleosomes, histones, SSA / Ro-52, RIB and RNP / Sm, speckled pattern (35.6%) with Sm, RNP, SSA/Ro-52, SSB, Sm and RIB; nucleolar pattern with Scl-70, Sm, RNP and centromere pattern with CENP-B. The methodology indicated that, cytoplasmic pattern noted in ANA also needs to be correlated with primate liver in a biochip, which should prompt further decision for a request for line immunoassay and it is preferable for two pathologists to report independently and sign out a consensus ANA report for better predictive value.
As a definite correlation between the ANA patterns and the group of antibodies was detected by line immunoassay, one could predict presence of certain specific auto antibodies for a particular ANA pattern identified. This may restrict one from requesting for line immunoassay, which is expensive and economizes on the cost of laboratory investigations in a developing country like India. Thus, screening of sera by ANA-IIF method alone may suffice and probably reduce the expense of detailed immunological work-up with minimal loss in diagnostic accuracy. This study, the first of its kind in India, provides database and reference for the Indian subpopulation.
众所周知,免疫状态、个体对疾病的反应以及产生的抗体类型因人而异、因地区而异,甚至可能因人群而异。西方文献中指出的迄今已与特定风湿性疾病相关的广泛特异性自身抗体,已被全世界广泛用作参考标准。迄今为止,在印度人群中,既没有关于自身抗体及其抗核抗体(ANA)模式与免疫特征相关性的研究工作,也没有相关数据。
了解印度研究人群血清中ANA模式与特定抗体之间的确切关联,并记录与西方的异同。
本前瞻性和回顾性双盲研究针对通过间接免疫荧光法和免疫印迹法进行ANA检测的南印度人群开展。
在为期27个月的研究期间,对因风湿性疾病寻求医疗帮助的南印度随机人群的血清样本采用间接免疫荧光(IIF)法和免疫印迹法进行ANA检测。血清样本使用HEp - 2010/肝脏生物芯片(猴)(EUROIMMUN AG)以1:100的稀释度进行处理。进一步用于免疫印迹法的血清样本在涂有重组和纯化抗原的尼龙条上以1:100稀释处理,这些抗原以离散线条形式存在,塑料背衬(EUROIMMUN AG)上涂有抗原nRNP/Sm、Sm、SSA、Ro - 52、SSB、Scl - 70、PM - Scl、PCNA、Jo - 1、CENP - B、双链DNA、核小体、组蛋白、核糖体蛋白 - P、抗线粒体抗体(AMA - M2)以及一条对照带。通过图像分析将反应强度与阳性对照线进行比较来进行分析。
获得的抗核抗体间接免疫荧光(ANA - IIF)模式可呈现出一定范围的特定抗体,如与双链DNA、核小体、组蛋白、SSA/Ro - 52、核糖体蛋白和RNP/Sm相关的均质型(45.5%),与Sm、RNP、SSA/Ro - 52、SSB、Sm和核糖体蛋白相关的斑点型(35.6%);与Scl - 70、Sm、RNP相关的核仁型以及与CENP - B相关的着丝粒型。该方法表明,ANA中观察到的胞质型也需要与生物芯片中的灵长类肝脏相关联,这应促使进一步决定是否进行免疫印迹法检测,并且最好由两位病理学家独立报告并签署一份共识ANA报告以获得更好的预测价值。
由于通过免疫印迹法检测到ANA模式与抗体组之间存在明确关联,因此可以针对所确定的特定ANA模式预测某些特定自身抗体的存在。这可能会限制人们进行昂贵的免疫印迹法检测,从而在像印度这样的发展中国家节省实验室检查成本。因此,仅通过ANA - IIF法筛查血清可能就足够了,并且可能在诊断准确性损失最小的情况下降低详细免疫检查的费用。本研究是印度同类研究中的首例,为印度亚人群提供了数据库和参考。